PTGS2 and cancer: In conclusion, our findings support a model whereby increased COX-2 expression and the resulting augmented PGE2 synthesis, by modulating the inflammatory features of cancer cells post-cytotoxic treatment, limit T cell-mediated tumour immunity (Fig. 1).